In Brief: Trademarks
Executive Summary
Trademarks: Takeda lists Blopres for antihypertensive agents in the U.S. Patent & Trademark Office's March 21 Official Gazette. Ares lists Zyfolex for recombinant gonadotropins, and Abbott's new trademarks include Oncolet for oral carrier preparations and Gabin for neurological pharmaceutical preparations. Abbott is pursuing development of tiagabine for treatment of epilepsy. Amgen claims Stemgen for interferon in treatment of viral, neoplastic and autoimmune diseases. Sanofi lists Skelid for products treating Paget's disease and osteoporosis...